Related Experiment Videos
Low-dose, long-term macrolide therapy in asthma: An overview
Umur Hatipoglu1, Israel Rubinstein
1Section of Respiratory and Critical Care Medicine, Department of Medicine and Department of Biopharmaceutical Sciences, Colleges of Medicine and Pharmacy, University of Illinois at Chicago, and VA Chicago Health Care System, Chicago, Illinois 60612, U,S,A. IRubinst@uic.edu
Clinical and Molecular Allergy : CMA
|March 17, 2004
Summary
Macrolide antibiotics, at low doses over time, offer anti-inflammatory benefits beyond infection control. This review focuses on their immunomodulatory effects in asthma patients.
Area of Science:
- Pharmacology
- Immunology
- Respiratory Medicine
Background:
- Macrolides are antimicrobials derived from Streptomycetes.
- Long-term, low-dose macrolides exhibit immunomodulatory and tissue reparative effects.
- These effects are distinct from their anti-infective properties.
Purpose of the Study:
- To outline the immunomodulatory effects of macrolide antibiotics.
- Focus on macrolide use in asthma patients.
Main Methods:
- Review of experimental and clinical evidence.
- Analysis of studies on macrolide antibiotics in various lung disorders.
Main Results:
- Macrolides demonstrate salutary effects in conditions like asthma.
- Evidence suggests distinct immunomodulatory actions.
Conclusions:
- Macrolide antibiotics possess significant immunomodulatory potential in asthma.
- Further research into these non-antimicrobial effects is warranted.